Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder

Comprehensive Psychiatry

Volumn 66, Issue , 2016, Pages 146-156

  Post, Robert M ^a,b   Leverich, Gabriele S ^a   Kupka, Ralph ^c   Keck, Paul E ^d,e   McElroy, Susan L ^d,e   Altshuler, Lori L ^f,g   Frye, Mark A ^h   Rowe, Michael ^a   Grunze, Heinz ⁱ   Suppes, Trisha ^j,k   Nolen, Willem A ^l  

^a Bipolar Collaborative Network   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e LINDNER CENTER OF HOPE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h MAYO CLINIC   (United States)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^l UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; TRANQUILIZER; TRIAZINE DERIVATIVE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHILD ABUSE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CORRELATION ANALYSIS; DRUG USE; FAMILY HISTORY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MOOD DISORDER; ONSET AGE; PARENT; PHYSICAL ABUSE; PROGNOSIS; SEXUAL ABUSE; STATISTICAL ANALYSIS; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT RESPONSE; CHILD; COMBINATION DRUG THERAPY; DRUG DEPENDENCE; FEMALE; GENETICS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PSYCHOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHILD; CHILD ABUSE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; PARENTS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 84960950421     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2016.01.009     Document Type: Article

References (41)

1. L.L. Judd, H.S. Akiskal, P.J. Schettler, W. Coryell, J. Maser, J.A. Rice, and et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord 73 2003 19 32
2. J.F. Goldberg, J.L. Garno, and M. Harrow Long-term remission and recovery in bipolar disorder: a review Curr Psychiatry Rep 7 2005 456 461
3. A.A. Nierenberg, E.S. Friedman, C.L. Bowden, L.G. Sylvia, M.E. Thase, T. Ketter, and et al. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium Am J Psychiatry 170 2013 102 110
4. D.E. Kemp, K. Gao, E.B. Fein, P.K. Chan, C. Conroy, S. Obral, and et al. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder Bipolar Disord 14 2012 780 789
5. R.H. Perlis, S. Miyahara, L.B. Marangell, S.R. Wisniewski, M. Ostacher, M.P. DelBello, and et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) Biol Psychiatry 55 2004 875 881
6. R.M. Post, K.D. Denicoff, G.S. Leverich, L.L. Altshuler, M.A. Frye, T.M. Suppes, and et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method J Clin Psychiatry 64 2003 680 690 [quiz 738-9]
7. W.A. Nolen, D.A. Luckenbaugh, L.L. Altshuler, T. Suppes, S.L. McElroy, M.A. Frye, and et al. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network Am J Psychiatry 161 2004 1447 1454
8. R.W. Kupka, D.A. Luckenbaugh, R.M. Post, T. Suppes, L.L. Altshuler, P.E. Keck Jr., and et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients Am J Psychiatry 162 2005 1273 1280
9. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, and W. Nolen Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP Psychiatry Res 73 1997 159 171
10. R.M. Post, G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, P.E. Keck, and et al. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany Int Clin Psychopharmacol 26 2011 96 106
11. R.M. Post, L.L. Altshuler, M.A. Frye, T. Suppes, P.E. Keck Jr., S.L. McElroy, and et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder J Clin Psychiatry 71 2010 1176 1186 [quiz 252-3]
12. J.N. Holtzman, S. Miller, F. Hooshmand, P.W. Wang, K.D. Chang, S.J. Hill, and et al. Childhood-compared to adolescent-onset bipolar disorder has more statistically significant clinical correlates J Affect Disord 179 2015 114 120
13. R. Post, and G. Leverich Treatment of bipolar illness: A casebook for clinicians and patients 2008
14. T.A. Ketter Handbook of diagnosis and treatment of bipolar disorder Am Psych Pub 2010
15. R.M. Post, G.S. Leverich, R.W. Kupka, P.E. Keck Jr., S.L. McElroy, L.L. Altshuler, and et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood J Clin Psychiatry 71 2010 864 872
16. G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, S.L. McElroy, P.E. Keck Jr., and et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers Am J Psychiatry 163 2006 232 239
17. S.L. McElroy, M.A. Frye, L.L. Altshuler, T. Suppes, G. Hellemann, D. Black, and et al. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders Bipolar Disord 9 2007 426 434
18. P.E. Keck Jr., M. Versiani, S. Potkin, S.A. West, E. Giller, and K. Ice Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial Am J Psychiatry 160 2003 741 748
19. K.D. Denicoff, E.E. Smith-Jackson, E.R. Disney, R.L. Suddath, G.S. Leverich, and R.M. Post Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p) J Psychiatr Res 31 1997 593 603
20. K.D. Denicoff, E.E. Smith-Jackson, E.R. Disney, S.O. Ali, G.S. Leverich, and R.M. Post Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder J Clin Psychiatry 58 1997 470 478
21. K.D. Denicoff, G.S. Leverich, W.A. Nolen, A.J. Rush, S.L. McElroy, P.E. Keck, and et al. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness Psychol Med 30 2000 1391 1397
22. R.M. Post, W.A. Nolen, R.W. Kupka, K.D. Denicoff, G.S. Leverich, P.E. Keck Jr., and et al. The Stanley Foundation Bipolar Network. I. Rationale and methods Br J Psychiatry Suppl 41 2001 s169 s176
23. P. Grof, A. Duffy, P. Cavazzoni, E. Grof, J. Garnham, M. MacDougall, and et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry 63 2002 942 947
24. M. Alda, M. Passmore, J. Garnham, A. Duffy, M. MacDougall, and M. Munro Clinical presentation of bipolar disorders responsive to lithium or lamotrigine Int J Neuropsychopharmacol 2002
25. W. Greil, N. Kleindienst, N. Erazo, and B. Muller-Oerlinghausen Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder J Clin Psychopharmacol 18 1998 455 460
26. C.L. Bowden, J.R. Calabrese, S.L. McElroy, L. Gyulai, A. Wassef, F. Petty, and et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group Arch Gen Psychiatry 57 2000 481 489
27. J.R. Geddes, G.M. Goodwin, J. Rendell, J.M. Azorin, A. Cipriani, M.J. Ostacher, and et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet 375 2010 385 395
28. R.M. Post, L. Altshuler, R. Kupka, S. McElroy, M.A. Frye, M. Rowe, and et al. More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment J Affect Disord 160 2014 27 33
29. A.C. Swann, C.L. Bowden, J.R. Calabrese, S.C. Dilsaver, and D.D. Morris Mania: differential effects of previous depressive and manic episodes on response to treatment Acta Psychiatr Scand 101 2000 444 451
30. J.R. Calabrese, M.D. Shelton, D.J. Rapport, S.E. Kimmel, and O. Elhaj Long-term treatment of bipolar disorder with lamotrigine J Clin Psychiatry 63 Suppl. 10 2002 18 22
31. M.J. Passmore, J. Garnham, A. Duffy, M. MacDougall, A. Munro, C. Slaney, and et al. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine Bipolar Disord 5 2003 110 114
32. A. Duffy, M. Alda, R. Milin, and P. Grof A consecutive series of treated affected offspring of parents with bipolar disorder: is response associated with the clinical profile? Can J Psychiatr Rev Can Psychiatr 52 2007 369 376
33. M.M. Sidor, and G.M. Macqueen Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis J Clin Psychiatry 72 2011 156 167
34. I. Pacchiarotti, D.J. Bond, R.J. Baldessarini, W.A. Nolen, H. Grunze, R.W. Licht, and et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders Am J Psychiatry 170 2013 1249 1262
35. G.S. Sachs, A.A. Nierenberg, J.R. Calabrese, L.B. Marangell, S.R. Wisniewski, L. Gyulai, and et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med 356 2007 1711 1722
36. S.N. Ghaemi, A.P. Wingo, M.A. Filkowski, and R.J. Baldessarini Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks Acta Psychiatr Scand 118 2008 347 356
37. L. Altshuler, T. Suppes, D. Black, W.A. Nolen, P.E. Keck Jr., M.A. Frye, and et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up Am J Psychiatry 160 2003 1252 1262
38. R.H. Perlis, M.J. Ostacher, D.J. Miklowitz, J.W. Smoller, E.B. Dennehy, C. Cowperthwait, and et al. Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report J Clin Psychiatry 71 2010 194 200
39. R.M. Post, G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, S.L. McElroy, and et al. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients J Clin Psychiatry 73 2012 924 930
40. R.M. Post, K. Chang, and M.A. Frye Paradigm shift: preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention J Clin Psychiatry 74 2013 167 169
41. L.V. Kessing, H.V. Hansen, A. Hvenegaard, E.M. Christensen, H. Dam, C. Gluud, and et al. Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial Br J Psychiatry J Ment Sci 202 3 2013 212 219